FLASH NEWS
Health Ministry scandal, secretly increases prices of reimbursed medicines, suspicions of favoritism towards certain companies
2026-01-31 20:15:30 / AKTUALITET
The Ministry of Health has been involved in a serious scandal with drug reimbursement prices, where the calculation procedure is not only unclear, but raises serious suspicions of manipulation and favoritism towards certain companies.
First, the process has been conducted without any real consultation with pharmaceutical companies, which are direct parties to the reimbursement system. The Ministry has not taken on board any of their demands and has not provided transparency on the methodology used to calculate prices.
Second, the price change was published on a Saturday, a day when the state administration does not function normally. This raises an elementary question:
Does the Ministry of Health work on Saturday, or were the decisions made earlier and deliberately announced on a dead day to avoid reactions?
This detail is not formal. It is a classic technique for passing controversial decisions without public debate and without immediate opposition.
But the biggest scandal lies in the calculation of reimbursement prices themselves. The ministry has publicly boasted that it has made a "fantastic calculation", while the figures show the opposite. Price increases range from 3% to 4000%.
An increase of up to 4000% is not a reform. It is not a correction. It is not even a technical error.
It is pure financial abuse.
This raises several fundamental questions, which the Ministry has not yet answered:
- Why do some products have minimal growth, while others explode to dizzying numbers?
- Which companies benefit from these extreme increases?
- Is this a preferential scheme designed to favor certain operators connected to power?
- Who designed the calculation formula and on what real economic grounds?
If the price increases were uniform and justified by the market, inflation, or real costs, we would have a normal debate. But when the differences range from 3% to 4000%, we are dealing with selective and deliberate treatment.
This scandal does not only affect pharmaceutical companies. It directly affects the state budget, the reimbursement fund, and ultimately the citizen, who will either pay more or face a shortage of medicines.
The Ministry of Health has a legal and moral obligation to make transparent:
- calculation methodology,
- the full list of beneficiary products and companies,
- the justification for the extreme increases,
- and the names of the officials who signed this decision.
Without these, any "fantastic calculation" remains just a facade for a serious financial affair, which requires immediate administrative and criminal investigation.
This is not just a technical error.
It is an alarm about the capture of the reimbursement system in favor of narrow interests and to the detriment of the public interest./ Pamphlet
Happening now...
Rama dhe Berisha “rrëzohen” nga rasti Dodik
Nga Bato Kosova
ideas
The great loneliness of the West and liberal democracy
Nga The Economist
Corruption money is buying political time.
Nga Taulanda Jupi
top
TRENDING 
services
- POLICE129
- STREET POLICE126
- AMBULANCE112
- FIREFIGHTER128